P3 Health Partners (NASDAQ:PIII – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.63) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.89) by $1.26, FiscalAI reports. The company had revenue of $386.38 million for the quarter, compared to analysts’ expectations of $377.80 million.
Here are the key takeaways from P3 Health Partners’ conference call:
- Adjusted EBITDA reached $54 million in Q2, versus a $17 million loss a year earlier, bringing first-half EBITDA to $80 million. However, approximately $45 million of Q2 EBITDA came from favorable payer settlements and prior-year development, with underlying Q2 EBITDA of about $9 million.
- The company raised its 2026 adjusted EBITDA outlook to $80 million–$110 million, with a $95 million midpoint, citing improved payer economics, medical-cost performance, and greater earnings predictability.
- First-half Medicare Advantage medical-cost trend was 1.8% below the 2025 baseline, supported by utilization management, payment integrity, care management, quality execution, and expanded AI-enabled point-of-care tools reaching more than 65,000 members.
- At-risk membership declined to approximately 105,000 from 116,000 a year earlier following portfolio exits, while cash and equivalents stood at only $21 million at quarter-end. Management also expects normal seasonal medical-expense pressure in the second half.
- The Nebraska market is progressing as planned, with P3 providing services in 2027 before assuming full risk in 2028, reflecting management’s deliberate approach to geographic expansion and risk exposure.
P3 Health Partners Stock Performance
PIII stock opened at $12.83 on Tuesday. P3 Health Partners has a one year low of $1.52 and a one year high of $16.89. The firm has a market cap of $92.89 million, a price-to-earnings ratio of -0.33 and a beta of 1.63. The firm has a 50-day simple moving average of $10.98 and a two-hundred day simple moving average of $6.40.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Report on P3 Health Partners
About P3 Health Partners
P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.
The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.
Featured Stories
- Five stocks we like better than P3 Health Partners
- Caterpillar’s Blowout Quarter May Point to More Industrial Winners
- Jeff Bezos’ Amazon Sale Looks Less Alarming Than the Headline Suggests
- 3 Overlooked Stocks Analysts Still Like as AI Trades Get Crowded
- China’s Athleisure Boom Is Not Lifting Every Brand Equally
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
